Eric Venker Roivant Sciences Ltd. (ROIV) insider trading activity

Eric Venker is President & Immunovant CEO of Roivant Sciences Ltd.. Currently has a direct ownership of 1.65 Million shares of ROIV, which is worth approximately $33.6 Million. The most recent transaction as insider was on Mar 20, 2025, when has been sold 315,522 shares (Common Shares) at a price of $11.06 per share, resulting in proceeds of $3,489,673. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.65M

9.94% 3M change

123.3% 12M change

Total Value Held $33.6 Million

Eric Venker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 20 2025	SELL Open market or private sale	$3,489,673 $11.06 p/Share	315,522 Reduced 24.75%	959,457 Common Shares
Mar 20 2025	SELL Payment of exercise price or tax liability	$120,066 $10.97 p/Share	10,945 Reduced 1.24%	874,979 Common Shares
Mar 20 2025	BUY Exercise of conversion of derivative security	$1,540,000 $3.85 p/Share	400,000 Added 23.88%	1,274,979 Common Shares
Feb 20 2025	SELL Payment of exercise price or tax liability	$117,330 $10.72 p/Share	10,945 Reduced 1.22%	885,924 Common Shares
Feb 20 2025	SELL Open market or private sale	$1,065,000 $10.65 p/Share	100,000 Reduced 10.03%	896,869 Common Shares
Feb 20 2025	BUY Exercise of conversion of derivative security	$385,000 $3.85 p/Share	100,000 Added 9.12%	996,869 Common Shares
Feb 13 2025	SELL Open market or private sale	$2,271,987 $10.42 p/Share	218,041 Reduced 19.56%	896,869 Common Shares

Feb 13 2025	BUY Exercise of conversion of derivative security	$1,155,000 $3.85 p/Share	300,000 Added 21.2%	1,114,910 Common Shares
Feb 12 2025	SELL Open market or private sale	$2,289,053 $10.53 p/Share	217,384 Reduced 22.89%	732,294 Common Shares
Feb 12 2025	BUY Exercise of conversion of derivative security	$1,155,000 $3.85 p/Share	300,000 Added 22.52%	1,032,294 Common Shares
Jan 21 2025	SELL Open market or private sale	$1,128,000 $11.28 p/Share	100,000 Reduced 12.01%	732,294 Common Shares
Jan 21 2025	BUY Exercise of conversion of derivative security	$385,000 $3.85 p/Share	100,000 Added 10.73%	832,294 Common Shares
Jan 20 2025	SELL Payment of exercise price or tax liability	$96,804 $11.15 p/Share	8,682 Reduced 1.17%	732,294 Common Shares
Dec 30 2024	SELL Open market or private sale	$2,050,704 $11.54 p/Share	177,704 Reduced 19.34%	740,976 Common Shares
Dec 30 2024	BUY Exercise of conversion of derivative security	$962,500 $3.85 p/Share	250,000 Added 21.39%	918,680 Common Shares
Dec 27 2024	SELL Open market or private sale	$2,090,958 $11.82 p/Share	176,900 Reduced 20.92%	668,680 Common Shares
Dec 27 2024	BUY Exercise of conversion of derivative security	$962,500 $3.85 p/Share	250,000 Added 22.82%	845,580 Common Shares
Dec 20 2024	SELL Payment of exercise price or tax liability	$126,633 $11.57 p/Share	10,945 Reduced 1.8%	595,580 Common Shares
Dec 20 2024	SELL Open market or private sale	$1,149,000 $11.49 p/Share	100,000 Reduced 14.38%	595,580 Common Shares
Dec 20 2024	BUY Exercise of conversion of derivative security	$385,000 $3.85 p/Share	100,000 Added 12.57%	695,580 Common Shares
Nov 20 2024	SELL Payment of exercise price or tax liability	$125,758 $11.49 p/Share	10,945 Reduced 1.77%	606,525 Common Shares
Nov 20 2024	SELL Open market or private sale	$1,132,000 $11.32 p/Share	100,000 Reduced 14.15%	606,525 Common Shares
Nov 20 2024	BUY Exercise of conversion of derivative security	$385,000 $3.85 p/Share	100,000 Added 12.4%	706,525 Common Shares
Oct 21 2024	SELL Open market or private sale	$1,165,000 $11.65 p/Share	100,000 Reduced 13.94%	617,470 Common Shares
Oct 21 2024	BUY Exercise of conversion of derivative security	$385,000 $3.85 p/Share	100,000 Added 12.23%	717,470 Common Shares

Also insider at

IMVT

Immunovant, Inc. Healthcare

Chief Executive Officer

Eric Venker

President & Immunovant CEO

London, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Value

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Roivant Sciences Ltd.

Track Activities on ROIV

Account